Stay updated on Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6 in the page footer. This reflects a software update to the page's metadata rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-08-29T23:35:33.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.4 to v3.6.5, signaling a maintenance update to the page rather than a substantive change to study information.
    Difference
    0.1%
    Check dated 2026-08-08T19:09:02.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a page update without changes to the study information.
    Difference
    0.1%
    Check dated 2026-07-25T12:56:53.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.2 to v3.6.3, indicating a new version of the page. It represents a system or template update rather than changes to trial details.
    Difference
    0.1%
    Check dated 2026-07-03T23:19:56.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.6.2, indicating a minor maintenance update to the page. There is no change to the study details or navigation.
    Difference
    0.1%
    Check dated 2026-06-26T23:58:05.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Enrollment has closed for this study ('No longer looking for participants'), reflecting termination of accrual. New user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with a minor header formatting change (Intervention/Treatment) and a revision note (Revision: v3.6.0).
    Difference
    0.6%
    Check dated 2026-06-12T14:51:00.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.